Background: Several lifestyle factors have been associated with risk of lethal prostate cancer, but little is known about their combined effect. Our objective was to develop and apply a lifestyle score for prevention of lethal prostate cancer.
Identification of Prostate Cancer Cases and Outcomes
Self-reported, incident cases of prostate cancer in the PHS and HPFS (1986 HPFS ( -2010 were confirmed through medical record and pathology report review. Clinical T-stage, Gleason score, prostate cancer treatments, prostate-specific antigen (PSA) values at diagnosis and throughout follow-up and occurrence of metastases were ascertained from medical records and questionnaires sent to prostate cancer survivors and their physicians after diagnosis. An endpoint committee determined cause of death through death certificates and medical record review and, secondarily, via next of kin. The primary outcome for this analysis was lethal prostate cancer, defined as prostate cancer death or metastasis to the bones or other organs, excluding lymph nodes.
Assessment of Exposure Variables
The questionnaires used to assess diet, physical activity, and self-reported body weight in the HPFS have been validated, as previously described (20, (22) (23) (24) . The FFQ in the PHS was modeled after the HPFS FFQ, and we expect the validity in PHS to be similar to HPFS, given their similar professions and distribution of demographic characteristics.
Body mass index (BMI; kg/m 2 ): At baseline, men reported their current height and weight. Body weight was updated biennially in HPFS and nine times over follow-up in PHS. Physical activity was assessed at baseline and biennially in the HPFS. Men reported the average time per week spent over the past year doing leisure-time physical activities, as previously described (23) . Activities were classified according to their metabolic equivalent of task (MET) value; those that require six or more METs were considered vigorous (25) . Walking pace was updated every two to four years. In the PHS, physical activity was assessed at baseline and four times during follow-up. Participants were asked how often they "exercised to sweat" in six categories, ranging from rarely/never to daily. Current smoking status was assessed biennially in the HPFS and at baseline and four times over follow-up in the PHS. Past smokers at baseline reported when they quit.
Dietary exposures: Participants reported how often they consumed a specified portion size, from never or less than one serving per month to six or more servings per day for approximately 140 items in HPFS and 61 items in PHS. We calculated the average cumulative intake during follow-up when possible (26) . For example, the average intake from 1986, 1990, and 1994 HPFS FFQs was used for the 1994 to 1998 exposure. In the PHS, there were too few dietary measures to calculate cumulative average intake; fatty fish was evaluated once between 1982 and 1985, and processed meat was evaluated as hot dog intake once between 1982 and 1985 and as hot dogs/bacon/processed meats once between 2000 and 2002.
Population for Analysis
The populations for analysis included cohort participants alive and free of diagnosed cancer, except nonmelanoma skin cancer at the start of analysis (1990 for HPFS and 1987 for PHS), after imposing a four-year lag to reduce the potential for an effect of undiagnosed aggressive prostate cancer on these lifestyle behaviors (reverse causation). For example, we applied participants' 1994 lifestyle score to deaths occurring between 1998 and 2000, their 1996 lifestyle score to deaths occurring between 2000 and 2002, and so on. We excluded 6.5% of men in HPFS and 4.0% of men in PHS who were missing the lifestyle score, leaving 42 701 men in HPFS and 20 324 in PHS in the final analysis.
Development of the Healthy Lifestyle Score in HPFS
We dichotomized each lifestyle factor in the HPFS based on standard definitions (BMI) or previously reported cut-points (all other factors) from the HPFS, as well as other independent cohorts (7, 10, 11, 14, 18, 27) . Men were assigned one point for each healthy lifestyle factor (range = 0-6). Healthy lifestyle factors were: BMI of less than 30 kg/m 2 , high vigorous physical activity, never smoker or quit 10 or more years ago, high intake of tomatoes and fatty fish, and low intake of processed meat. To evaluate the role of diet independent of BMI, smoking status, and physical activity, we also calculated a score using only the dietary factors (range = 0-3).
Application of the Healthy Lifestyle Score in PHS
The phrasing of certain questions and the categorical responses varied somewhat between HPFS and PHS. For example, the HPFS questionnaire assessed five tomato items and PHS questionnaire assessed two tomato items. Thus, when necessary, we applied different but comparable cut-points in the PHS (Table 1) . All cut-point definitions were determined prior to data analysis in the PHS (a priori) to avoid overfitting the data.
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Statistical Analyses
Participants contributed person-time from the date of return of the 1990 questionnaire in HPFS and from 1987 in PHS until lethal prostate cancer diagnosis, death, or end of follow-up, whichever occurred first. End of follow-up was January 2010 in both HPFS and PHS. The event date for lethal prostate cancers was the date of diagnosis of metastases or death from prostate cancer, whichever occurred first. We updated exposure throughout follow-up until development of lethal disease, ignoring date of initial diagnosis, because we hypothesized that this exposure window would be most etiologically relevant to the development and progression of lethal prostate cancer. Secondarily, we conducted an analysis in which we stopped updating exposures at the date of prostate cancer diagnosis. To evaluate the potential of confounding by PSA screening, we also conducted a sensitivity analysis limited to an intensely screened HPFS subcohort, defined as men who reported PSA screening on 50% or more of the follow-up questionnaires from 1994 onward (PSA screening was first evaluated in 1994). We also considered models adjusted for height, intake of calcium, low fat dairy, whole milk, and coffee, energy, and selenium supplementation. There was little evidence of confounding by these factors, so they were not included in our final models. In the HPFS, we carried forward exposure data from the most recent questionnaire if data were missing (on average, 10.4% of men per cycle). In the PHS, we carried forward exposure data if: 1) the lifestyle factor was not assessed in a given cycle (number of assessments listed in Table 1 ) or 2) data were missing (on average, 4.4% of men per cycle).
We used Cox proportional hazards regression to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations of the lifestyle score and risk of lethal prostate cancer. Age-adjusted models used age as the time scale, stratified by calendar time in two-year intervals in the HPFS and one-year intervals in the PHS (the frequency of follow-up questionnaires). Cross-product terms of the scores by a function of time were added to the models to check the proportionality assumption; no violation was found. Multivariable models were additionally adjusted for race (white, nonwhite, missing), diabetes (yes, no, missing), multivitamin use (yes, no, missing), vitamin E use (yes, no, missing), and random assignment status (aspirin, beta-carotene, both, or neither) for PHS. When examining the diet score, we adjusted for smoking, BMI, and vigorous physical activity (see categories in Table 1 article
where p e is the exposed proportion in NHANES and HR is the hazard ratio from the multivariable model estimates from HPFS.
Results
Among 42 701 men in HPFS and 20 324 men in PHS initially free of cancer, 5597 men in HPFS and 3083 men in PHS were diagnosed with prostate cancer, and 576 and 337 of these were lethal, respectively. The median follow-up time to lethal prostate cancer diagnosis (metastasis or prostate cancer-specific death) was 12. Table 2 . The PHS participants were slightly older than the HPFS. Distributions were similar across cohorts and time. Differences in the consumption of processed meats are likely because of fewer processed meat items queried on the PHS FFQ than the HPFS FFQ (Table 1) . Table 3 shows the age-adjusted and multivariable model results for the lifestyle and diet-only scores and risk of lethal prostate cancer. In both cohorts, a higher lifestyle score was inversely associated with risk, although the results were not statistically significant in PHS. Men with 5 to 6 vs 0 to 1 points had a 68% decreased risk of lethal prostate cancer (HR = 0.32, 95% CI = 0.19 to 0.52, P trend < .001) in the HPFS and 38% decreased risk (HR= 0.62, 95% CI = 0.30 to 1.26, P trend = .09) in the PHS. A 1-point increase in the score was associated with a 20% decreased risk in the HPFS (95% CI = 0.73 to 0.87, P trend < .001) and 9% decreased risk in the PHS (95% CI = 0.81 to 1.02, P trend = .12).
Similarly, an inverse association was observed when examining the diet-only score, but the relation was statistically significant only in the HPFS. Men with 3 vs 0 points had a 46% decreased risk of lethal prostate cancer (HR = 0.54, 95% CI = 0.30 to 0.96, P trend = .0007) in the HPFS and a 30% decreased risk (HR = 0.70, 95% CI = 0.40 to 1.23, P trend = .25) in the PHS, adjusting for potential confounders as well as BMI, physical activity, and smoking status (Table 3) . A 1-point increase in the diet-only score was associated with a 19% decreased risk (95% CI = 0.71 to 0.91, P trend = .0007) in the HPFS and 9% decreased risk in the PHS (95% CI = 0.78 to 1.07, P trend = .25). Our results were similar when we stopped updating exposures at the time of prostate cancer diagnosis ( Table 3) .
The results were similar when restricting to men in the HPFS who reported frequent PSA tests (n = 29 330, 400 events). Compared with men with 0 to 1 points, those with 2, 3, 4, and 5 to 6 points for the lifestyle score had hazard ratios of: 0.59 (95% CI = 0.38 to 0.89), 0.56 (95% CI = 0.38 to 0.83), 0.37 (95% CI = 0.24 to 0.57), and 0.27 (95% CI = 0.15 to 0.49), respectively. The hazard ratios for the dietary score for men with 1, 2, and 3 points were 0.78 (95% CI = 0.60 to 1.00), 0.68 (95% CI = 0.49 to 0.95), and 0.53 (95% CI = 0.26 to 1.06), respectively. We could not conduct this sensitivity analysis in PHS because of insufficient data on PSA screening.
Hazard ratios and 95% confidence intervals for the individual lifestyle factors are presented in Table 4 for age-adjusted and multivariable models and show the relative contribution of each variable to the score: Factors with stronger hazard ratios contributed to a greater degree to the overall score compared with the factors with weaker hazard ratios. Results .0007
.001
.005
Lifestyle score, PHS ‡ 0-1 (less healthy) (Ref) .30
* Cox proportional hazards regression with two-sided P values. We used a four-to six-year lag for all exposures to reduce the potential for reverse causation. Follow-up for the Health Professionals Follow-up Study began in 1990, using exposures ascertained in 1986. Follow-up for PHS started in 1987, using exposures ascertained starting in 1982. CI = confidence interval; HPFS = Health Professionals Follow-up Study; HR = hazard ratio; PHS = Physicians' Health Study. † Adjusted for age in months (continuous), race (white, non-white, missing), diabetes (yes, no, missing), multivitamin use (yes, no, missing), and vitamin E use (yes, no, missing). We used age as the time scale, stratified by calendar time in months (HPFS) and two-year intervals (PHS). Additionally adjusted for randomization status (aspirin, beta-carotene, both, or neither) in the PHS. The multivariable model for the diet score was additionally adjusted for body mass index, physical activity, and smoking status. ‡ Lifestyle score is determined by number of healthy lifestyle factors: 0 (least healthy) -6 (more healthy). § Diet score is determined by number of healthy diet factors: 0 (least healthy) -3 (more healthy).
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Population-Attributable Risk
Using data from the NHANES, we calculated that 47% of hypothetical lethal prostate cancer cases could potentially be prevented if US adult men had five or more vs zero to four of the lifestyle factors ( Table 5 ), assuming that our findings represent causal associations. Engaging in vigorous physical activity had the highest potential impact on prevention of lethal prostate cancer (34%).
Discussion
In two large-scale prospective studies, a lifestyle score that included healthy weight, vigorous physical activity, not smoking, and consumption of tomatoes, fatty fish, and reduced intake of processed meat was associated with decreased risk of lethal prostate cancer. The score results were more pronounced in the HPFS compared with the PHS. Although we made the variables comprising the score as similar as possible across cohorts, differences in the phrasing and frequency of certain questions and foods collected-particularly for vigorous activity and tomatoes-could partially explain the different associations, as we collected more detailed information in HPFS. While we cannot be certain that these associations are causal, our results suggest that a healthy lifestyle may substantially reduce the risk of lethal prostate cancer. We also observed a modestly stronger inverse association in men who had PSA levels measured more frequently.
Our study has limitations. First, because of the self-reported exposure data, there is potential for measurement error. However, the questionnaires have been previously validated (20, 23, 24) as reliable sources of the exposure information, and any misclassification of exposure was likely random with respect to the outcome. As a result, it is possible that our findings underestimate the true relation between the lifestyle score and lethal prostate cancer. Second, while we cannot eliminate the potential for residual or unmeasured confounding, we carefully controlled for numerous factors and the age-adjusted and multivariable analyses provided similar results. Third, we dichotomized the lifestyle factors and assigned them one point for simplicity, but recognize that the associations between the factors and risk of lethal prostate cancer are likely continuous, not dichotomous. Hence, the reported hazard ratios for individual factors may be attenuated because of including men who may still derive a benefit at levels below our cut-points. Fourth, the HPFS and PHS are mostly white men with high socioeconomic status. However, each factor has been associated with lethal prostate cancer in other cohorts, suggesting that our results are generalizable to more diverse populations. Fifth, we acknowledge that the number of lethal outcomes in some of the subgroups is small, limiting our statistical power. A randomized trial of these lifestyle factors on risk of lethal prostate cancer is not feasible. Thus, further exploration in independent prospective cohorts is needed.
None of the several comprehensive reviews about prevention of advanced and lethal prostate cancer through diet and lifestyle (31) (32) (33) have attempted to quantify the combined effect of these factors on risk of lethal prostate cancer. Because these healthy behaviors are often correlated and potentially act through similar biologic mechanisms including hyperinsulinemia, insulin resistance, insulin-like growth factors and associated binding proteins, sex hormone regulation, inflammation, adipokine production and signaling, and oxidative stress (34, 35) , the combined score helps conceptualize lethal prostate cancer prevention as a constellation of lifestyle factors. For example, many of these mechanisms may underlie the relationship between obesity, physical activity, and lethal prostate cancer (36) (37) (38) (39) (40) . Indeed, our PAR analysis suggests that even a modest adoption of two or more lifestyle factors potentially could prevent many lethal prostate cancers in the general population.
In addition to the observed inverse association between the combined lifestyle score and lethal prostate cancer risk, our results for each individual factor, though not all statistically significant, are generally consistent with the current literature. In particular, high BMI has been strongly associated with increased risk of advanced and lethal prostate cancer in numerous observational studies and four meta-analyses (9, (41) (42) (43) . The proposed biologic mechanisms involve the insulin/insulin-like growth factor axis (44) (45) (46) , altered levels of sex hormones (47) , and adipokine signaling (48) (49) (50) . These mechanisms may be similar to those underlying the benefit of vigorous physical activity (51) . High prediagnostic C-peptide levels and low prediagnostic adiponectin levels, which are altered by BMI and physical activity, have been shown to be statistically significantly associated with lower risk of prostate cancer mortality (45). 
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Mounting evidence suggests that current smoking increases risk of aggressive and lethal prostate cancer (52, 53) . Smokers tend to have more advanced disease at diagnosis and worse outcomes after treatment (54, 55) . In our analyses, nonsmoking or quitting 10 or more years prior to diagnosis was statistically significantly inversely associated with lethal prostate cancer only when we stopped updating smoking status at diagnosis, suggesting that quitting early is important.
Fish consumption was unrelated to total prostate cancer in a meta-analysis of 12 cohort studies but with a statistically significant 63% reduction for prostate cancer mortality in a metaanalysis of four cohort studies (27) . High intake of fatty fish was related to a non-statistically significantly decreased risk of lethal prostate cancer in the present analysis. Likewise, tomato and lycopene consumption have been associated with lower risk of advanced and lethal prostate cancer in previous analyses of the HPFS (13) and in the PLCO (14) and EPIC (56) cohorts. In the present study, high tomato intake was associated with a non-statistically significant lower risk of lethal prostate cancer in HPFS but not in PHS; the HPFS questionnaire included tomato sauce intake (the major source of absorbable lycopene), which drove the association in HPFS, whereas the PHS questionnaire did not include that item.
High intake of processed meat was independently associated with increased risk of lethal prostate cancer in the HPFS and PHS. A meta-analysis of eight cohort studies reported a non-statistically significantly increased risk for high-grade or high-stage prostate cancer associated with high processed meat intake, though this is an imperfect surrogate for lethal disease (57) . We previously reported a non-statistically significant positive association with incident lethal prostate cancer (HR = 1.52, 95% CI = 0.89 to 2.61) for processed red meat at levels of three or more servings per week (17, 18) .
In conclusion, our analysis suggests that specific lifestylerelated factors, including engaging in vigorous physical activity, maintaining a healthy body weight, not smoking, consuming fatty fish and tomatoes, and limiting intake of processed meat, may reduce risk of lethal prostate cancer. We estimated that 47% of lethal prostate cancer cases could be prevented in the United States if adult men over age 60 years had five or more of these healthy lifestyle factors.
